COMPOSITIONS DE 1,2,4-OXADIAZOLE ORALEMENT ACTIVES POUR UN TRAITEMENT DE SUPPRESSION DE MUTATIONS NON-SENS

• 收藏
• 分享

专利权人:

PTC THERAPEUTICS; INC.

发明人:

HIRAWAT, SAMIT,MILLER, LANGDON

申请号：

CA2603402

公开号：

CA2603402C

申请日:

2006.04.06

申请国别(地区):

CA

年份:

2017

代理人:

摘要：

The present invention relates to specific doses of and dosing regimens forusing a 1,2,4-oxadiazole benzoic acid compound in treating or preventingdiseases associated with nonsense mutations. In particular, the inventionrelates to specific doses and dosing regimens for the use of 3-[5-(2-fluoro-phenyl)-[l,2,4]oxadiazol-3-yl]-benzoic acid in mammals having diseasesassociated with nonsense mutations.

来源网站：

中国工程科技知识中心

来源网址：

http://www.ckcest.cn/home/